# CVS HEALTH CORPORATION (CVS) FY2026 Q2 Balance Sheet

- Company: CVS HEALTH CORPORATION (CVS)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-05, accession number 0000064803-26-000098
- Page: https://plicit.ai/financials/cvs/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/cvs-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 253,768,000,000 US dollars
- **Current assets**: 75,346,000,000 US dollars
- **Non-current assets**: 178,422,000,000 US dollars
- **Liabilities**: 173,869,000,000 US dollars
- **Current liabilities**: 87,041,000,000 US dollars
- **Non-current liabilities**: 86,828,000,000 US dollars
- **Equity**: 79,899,000,000 US dollars
- **Noncontrolling interest**: 197,000,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Accounts receivable, net**: 40,309,000,000 US dollars
- **Inventories**: 17,622,000,000 US dollars
- **Cash and cash equivalents**: 11,329,000,000 US dollars
- **Other current assets**: 3,457,000,000 US dollars
- **Investments**: 2,629,000,000 US dollars
- **Goodwill**: 85,478,000,000 US dollars
- **Long-term investments**: 33,247,000,000 US dollars
- **Intangible assets, net**: 24,644,000,000 US dollars
- **Operating lease right-of-use assets**: 14,451,000,000 US dollars
- **Property and equipment, net**: 13,168,000,000 US dollars
- **Other assets**: 7,434,000,000 US dollars
- **Pharmacy claims and discounts payable**: 26,203,000,000 US dollars
- **Accrued expenses and other current liabilities**: 22,477,000,000 US dollars
- **Accounts payable**: 17,167,000,000 US dollars
- **Health care costs payable**: 16,313,000,000 US dollars
- **Current portion of long-term debt**: 1,958,000,000 US dollars
- **Current portion of operating lease liabilities**: 1,914,000,000 US dollars
- **Other insurance liabilities**: 1,009,000,000 US dollars
- **Long-term debt**: 59,452,000,000 US dollars
- **Long-term operating lease liabilities**: 12,982,000,000 US dollars
- **Other long-term liabilities**: 6,112,000,000 US dollars
- **Other long-term insurance liabilities**: 4,516,000,000 US dollars
- **Deferred income taxes**: 3,766,000,000 US dollars
- **Retained earnings**: 65,398,000,000 US dollars
- **Common stock, par value $0.01: 3,200 shares authorized; 1,795 shares issued and 1,278 shares outstanding as of June 30, 2026 and 1,787 shares issued and 1,271 shares outstanding as of December 31, 2025 and capital surplus**: 50,968,000,000 US dollars
- **Accumulated other comprehensive income**: 188,000,000 US dollars
- **Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding**: 0 US dollars
- **Noncontrolling interests**: 197,000,000 US dollars
- **Treasury stock, at cost: 517 and 516 shares as of June 30, 2026 and December 31, 2025**: negative 36,852,000,000 US dollars
- **Gross equity (calculated)**: 116,751,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.